GP with terminal skin cancer issues stark warning - the symptoms aren't always what you think
Alastair Muir, 63, noticed a skin-coloured lesion on his heel back in 2018 and suspected that it was a wart or verruca, and attempted to have it frozen off.
But a biopsy taken later that year revealed the devastating truth; it was in fact melanoma — the deadliest type of skin cancer.
'Most people associate melanoma with pigmented moles that change or grow,' said the grandfather from Kinross, Scotland.
'It is important for people to know that it doesn't always present that way.
'I think people need to be aware that if you have anything on your skin that is different or changing then it is very worthwhile getting it checked out.'
It took several surgeries to remove the growth from his foot, resulting in months spent on crutches.
Mr Muir was free from the disease for three years, until his health took a turn for the worst in early 2023.
He began to suffer unusual problems with his vision, including night blindness.
Doctors originally suspected this could be multiple sclerosis, but further tests confirmed it was in fact a rare condition called melanoma associated retinopathy.
This is a uncommon complication of skin cancer whereby the disease triggers an autoimmune response telling the body's fighter proteins to attack the eyes.
In many cases, the condition can lead to permanent blindness.
Despite his extensive medical experience, the GP said he'd 'never heard' of the complication.
'Being told that I could go blind was a bigger and more frightening experience than being diagnosed with cancer,' he said.
He then began on a treatment known as plasma exchange, where blood is filtered to remove the harmful proteins, which is still being administered alongside steroids.
So far, the treatment has been working well to improve his sight.
However, later that year scans revealed that the cancer spread to his lymph nodes at the top of his leg and his pelvis.
Further surgeries to remove the disease proved unsuccesful, with the cancer continuing to spread.
At the end of 2023 doctors told Dr Muir that he had less than five years to live.
'It was essentially a death sentence,' he said.
Studies show that around two thirds of people with late stage melanoma will not survive longer than five years.
Speaking of his transition from doctor to patient Dr Muir said: 'It is fascinating. You can never imagine what it is like to be told that you have got cancer which is spreading, and you might go blind.
'It gave everybody a bit of a fright, I think. It becomes all consuming. It is all you can think about but at the same time you don't want to talk about it.
'All of a sudden people drop out of your life. It can be very lonely and quite difficult.'
Things may be starting to look up, however.
Dr Muir has been offered a modern type of cancer treatment called immunotherapy, which studies suggest could double his chances of surviving up to ten years.
The treatment is not without risk, as it may undo the progress made on his sight, but so far, the therapy appears to be going well.
Now, he aims to give back to those who helped him by participating in Sir Chris Hoy's Tour de 4 charity cycle event on Sunday, September 7th in Glasgow.
He will be doing his cycle on a fixed bike in the centre of the Sir Chris Hoy Veladrome, due to his impaired eyesight, for up to 20 minutes.
The sponsored cycle will raise money for the Melanoma-Me Foundation.
'When Chris Hoy spoke about his cancer I was very shocked because he is the greatest ever Olympian and has a lifestyle you wouldn't associate with ill health of any kind,' he said.
'It was inspiring that he reached out to help others. I want to be able to do the same.'
Six-time gold medallist Sir Chris Hoy announced in February last year that he had been diagnosed with stage four prostate cancer which is terminal.
The sports star said his charity cycle aims to change perceptions around stage four cancer, as well as raise money for vital charities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
6 minutes ago
- The Sun
Tesco urgently recalls popular beauty product over ‘serious health risk' as shoppers warned ‘do not use'
TESCO has urgently recalled a a popular beauty product found to pose a serious health risk. Shoppers have been warned "do not use" the product, and return it to a store if purchased. The supermarket giant's Kind & Pure Facial Cleansing Wipes have been pulled from shelves due to detection of a microbiological risk they have been found to contain. Following testing, Pluralibacter gergoviae was detected in batches of the product. This makes the product potentially unsafe to use, particularly for those vulnerable or with a compromised skin barrier. The recall includes two types of the Kind & Pure cleansing facial wipes, which are sold in packs of 24. One is the Fragrance Free " Camomile & Rosehip + Pro-Vitamin B5" biodegradable facial cleansing wipes. The other is the Vitamin C " Grapefruit & Cranberry Extract" radiant facial cleansing wipes. Both of these wipes have been stated to pose a "serious risk" to consumers by the Office for Product Safety & Standards. They have failed to meet the requirements of Regulation (EC) 1223/2009 or the Cosmetic Products Enforcement Regulations 2013. The Pluralibacter gergoviae bacteria found within the wipes is known to cause severe infections in people with weakenes immune systems or chronic illnesses. It has been linked to respiratory diseases, infections such as those in the eye, and cause symptoms like weakness, fever, nausea, and vomiting. Save with secret codes However, infections in healthy individuals are said to be rare. As part of corrective measures, the product regulator has advised: "If you have purchased an affected product, please do not use it. "Return your product to any Tesco store for a full refund. "No receipt is required." Those who have purchased either of the products are able to therefore get an automatic refund from Tesco stores. Recall of Tesco's facial wipes comes just after the supermarket chain also recalled three of their lunchtime favourites over fears of diarrhoea and vomiting if consumed. Three of their Pasta Salads were recalled in July over possible salmonella contamination, which has seen a significant rise in England. Included in the recall was Tesco's Basil Pesto and Semi Dried Tomato Pasta, Chicken and Chorizo Pasta, and Feta Semi Dried Tomato Pasta. The previous month, Tesco stores also recalled one of their cheeses which was found to be contaminated with a bacteria that causes meningitis and pregnancy loss. It was their popular Le Superbe Raclette swiss cheese, that was believed to contain listeria monocytogenes, a foodborne bacterium that can cause infection. Your product recall rights Chief consumer reporter James Flanders reveals all you need to know. Product recalls are an important means of protecting consumers from dangerous goods. As a general rule, if a recall involves a branded product, the manufacturer would usually have lead responsibility for the recall action. But it's often left up to supermarkets to notify customers when products could put them at risk. If you are concerned about the safety of a product you own, always check the manufacturer's website to see if a safety notice has been issued. When it comes to appliances, rather than just food items, the onus is usually on you - the customer - to register the appliance with the manufacturer as if you don't there is no way of contacting you to tell you about a fault. If you become aware that an item you own has been recalled or has any safety noticed issued against it, make sure you follow the instructions given to you by the manufacturer. They should usually provide you with more information and a contact number on its safety notice. In some cases, the manufacturer might ask you to return the item for a full refund or arrange for the faulty product to be collected. You should not be charged for any recall work - such as a repair, replacement or collection of the recalled item
Telegraph
16 minutes ago
- Telegraph
I told my son I have cancer. It was the hardest conversation I have ever had
In June this year, Paul Henderson received test results showing elevated PSA (prostate-specific antigen) levels. In this weekly diary, he will be sharing what life is like in the weeks that follow: the tests, the scans, the fear and what it's like when you have to sit down with your loved ones to discuss the possibility of cancer. It was a warm, sunny day in the middle of June, just after 2.30 pm, and I was sitting with my wife, Marilyn, in a generically nondescript doctor's office at Whipps Cross Hospital. Having spent the previous two months undergoing tests, scans, and biopsies for suspected prostate cancer, we were almost certain the news would be bad. But no matter how prepared we thought we were to hear the words, the formal diagnosis hit us both hard. After the initial shock, I tried to gather as much information as I could. Armed with a notepad and pen, I asked what I hoped were the right questions and tried to process what was coming back. In quick succession, Dr Chowdhury told me I had adenocarcinoma, the most common type of prostate cancer; that it was mid-stage, or stage 2, meaning it had spread beyond the prostate gland but not to the lymph nodes or beyond; and that my Gleason score was 7 (4+3), indicating a medium to high risk of the cancer spreading. 'Your cancer definitely looks treatable, but we will need to book you in for a bone scan to make sure it hasn't metastasised,' Dr Chowdhury said. 'It looks unlikely, but we need to be sure.' And if it has spread to the bones, I asked. 'That makes things more […] complicated.' The conversation lasted only about ten minutes, yet it felt both inconsequential and monumental in equal measure. Undoubtedly, this consultation was one of many the doctor would have, but in that moment, for Marilyn and I, it meant everything. We walked to the car park in silence, then held each other tightly. After all the waiting and anticipation, we finally had the news we had feared. And now I had to face the moment I had been dreading since April – telling our children. Despite living with the possibility of a cancer diagnosis for two months, we decided not to tell Nyah (22) and Fox (19) until we knew what we were dealing with. Nyah was living at home after graduating the previous summer, while Fox was in Durham studying for his first-year university exams, and we didn't want to distract him from his studies. We also felt it was important to break the news to them together. It was the hardest conversation I have ever had. The day after he came home, we sat them both down, and I told them the bad news. When it came to saying the words 'I have cancer', the C-word caught in my throat. After the initial shock, we all ended up in tears. Fox hugged me like his life depended on it. At 6ft 3in and with broad shoulders, he is bigger than his old man, but at that moment he was a little boy again. I held him closer than I had in years. Then it was Nyah's turn; she buried her head in my shoulder and squeezed hard. They then both took turns cuddling Marilyn. I felt incredibly proud of them all for being so brave. Once the initial shock had subsided, we talked. I explained the situation as best I could and tried to be as positive as possible. I didn't sugarcoat it, but I also wanted them to feel optimistic. Although the tumours in my prostate were fairly large, especially on the left side, the prognosis for stage 2 cancer is very good. Most patients, over 97 per cent, survive at least five years, and it is highly treatable. I am relatively young (56), fit, and healthy, so there was no need to panic, I reassured them. They then asked the same question: what happens next? That was a little harder to answer. At the end of my consultation, when the doctor had informed me I had cancer, he explained that I had two options for treatment. I would have to choose between surgery to remove the prostate or radiotherapy to try to kill the cancer cells. To help make that decision, he referred me to St Bartholomew's Hospital, where I would meet specialists from both areas to discuss the best way forward. In the meantime, while I waited for my appointment, there was the small matter of the bone scan that might just change everything… Frequently asked questions Answered by Prostate Cancer UK specialist nurses 1. What are the different types of prostate cancer and is there one type that's 'worse'? Most men diagnosed with prostate cancer have a type known as adenocarcinoma. There are, however, several much rarer forms of the disease. Because these are uncommon, they have not been studied as extensively, and we know far less about them. Some of these rare cancers can be more aggressive, meaning they may grow faster and are more likely to spread to other parts of the body. In many cases, men with a rare form of prostate cancer also have some adenocarcinoma present at the same time. Rare types of prostate cancer include: Neuroendocrine tumours (small cell or large cell) Glandular tumours (ductal, mucinous, or signet ring cell) Basal cell carcinoma Transitional cell carcinoma Prostate sarcoma Some of these rare cancers do not cause a rise in PSA levels. As a result, they may not be detected through a routine PSA blood test. Diagnosis may therefore only occur once the cancer has already spread outside the prostate, often following a biopsy. 2. What's a Gleason score? After a prostate biopsy, the tissue samples are examined under a microscope by a specialist doctor called a histopathologist. They check for the presence of cancer cells and describe their findings in a pathology report. Cancer cells in the prostate can look different depending on how likely they are to grow and spread. This appearance is given a Gleason grade, which ranges from 1 to 5. Grades 1 and 2 resemble normal prostate cells and are not usually reported. Prostate cancer is generally graded as Gleason 3, 4, or 5, the higher the number, the more aggressive the cancer is likely to be. The Gleason score is made up of two numbers: The most common grade seen in all the samples. The highest other grade found in the samples. These two numbers are added together, with the most common grade listed first. For example: If most cancer cells are pattern 4 and the highest other pattern is 3, the score is 4+3 = 7. A score of 3+3 = 6 usually indicates very slow-growing cancer. A score of 7 suggests faster-growing cancer, with 4+3 generally being more aggressive than 3+4. Scores of 8, 9, or 10 indicate faster-growing, more aggressive cancer that is more likely to spread. 3. What does it mean if cancer has metastasised? You might hear the terms metastasised, metastatic or advanced prostate cancer. These all mean the same thing – that the cancer has spread from the prostate to other parts of the body. This occurs when cancer cells travel through the blood or lymphatic system, so the cancer is no longer contained within the prostate. When this happens, prostate cancer is no longer curable, but treatments can be offered to help shrink the cancer and slow its growth or prevent further spread, such as hormone therapy. In recent years, research has developed a number of new treatments for advanced prostate cancer, meaning men are thankfully living longer than ever before. Metastatic prostate cancer can sometimes cause symptoms in the areas it has affected, for example bone pain, anaemia, or issues passing urine. At this stage, additional treatments may be required to address these symptoms, rather than the cancer itself, to improve quality of life and keep the patient as comfortable as possible.
The Independent
35 minutes ago
- The Independent
How ‘harmful' marketing could increase risk of obesity and cancer
A recent poll suggests that children and teenagers are frequently exposed to unhealthy food content online, with engagement increasing when shared by influencers. Cancer Research UK has called for stronger government action to protect young people from harmful marketing, citing concerns that 'harmful marketing could increase their risk of obesity and cancer in the future'. New legislation set to come into force next year will ban paid-for online advertising of foods high in fat, sugar, and salt, though the charity warns of potential loopholes and implementation delays. A survey by Cancer Research UK found that young people aged 11 to 21 often felt tempted or hungry after viewing online content featuring high fat, salt, and sugar foods. Concerns about food addiction are growing, with experts scheduled to meet in London to discuss the issue, as estimates suggest 10 million people in the UK are addicted to junk food.
